Weight loss · FAQ
How do the medicines in Verra’s weight loss category work?
Short answer
Semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GIP and GLP-1 receptors. These actions can affect appetite, fullness, and blood sugar. Results vary. Oral weight kit medicines work differently depending on their ingredients. A licensed physician in your state selects treatment based on your health needs.
Semaglutide and tirzepatide act on hormone signals involved in appetite and blood sugar control. Semaglutide targets GLP-1 receptors. Tirzepatide targets both GIP and GLP-1 receptors. They can reduce hunger and slow how quickly food leaves the stomach. Results vary. These effects do not mean that everyone will respond in the same way.
The Oral weight kit works according to its specific ingredients. Ask for the name, purpose, and safety information for each medicine before starting. Do not assume that an oral medicine works like an injectable GLP-1 medicine. Directions can also differ between oral and injectable products, even when the active ingredient is related.
Personalized dosing does not create a new, proven way for a medicine to work. Evidence for GLP-1 microdosing as a weight loss approach is limited. A licensed physician in your state decides whether a treatment is appropriate. Your plan should also address nutrition, activity, sleep, and health conditions that can affect weight.
Sources
Written by the Verra clinical team · Medical review pending
General information, not medical advice. If you're in crisis, call or text 988.